C4 Therapeutics, Inc.CCCCNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank57
5Y CAGR-53.0%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-53.0%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$1.81M-
2024$0.00-100.0%
2023$7.74M-
2022$0.00-
2021$0.00-100.0%
2020$78.44M-
2019$0.00-100.0%
2018$28.59M-